Press Releases

WASHINGTON, May 2 – Sen. Bernie Sanders (I-Vt.) on Wednesday night spoke on the floor of the U.S. Senate about the student protests taking place on college campuses across the country, and the ongoing, horrific humanitarian disaster in Gaza. Sanders’ remarks, as prepared for delivery, are below and can be watched live here: President, some of us have been out

WASHINGTON, May 1 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Thursday, May 2 at 10:00 a.m. ET will lead the committee in a hearing titled, “What Can Congress Do to Address the Severe Shortage of Minority Health Care Professionals and the Maternal Health Crisis?” “No one disputes that we have

WASHINGTON, April 30 — Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released the following statement after Federal Trade Commission (FTC) Chair Lina Khan announced that the FTC is taking action against the bogus patents Novo Nordisk filed to keep the outrageous price of Ozempic artificially high: Let me commend the Federal

WASHINGTON, April 25 — As negotiations continue at the World Health Organization (WHO) to establish the Pandemic Accord, Sen. Bernie Sanders (I-Vt.), Chairman of the Health, Education, Labor, and Pensions (HELP) Committee, sent a letter to the leaders of the international global pharmaceutical industry, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) President Albert Bourla and Director General David Reddy, to reconsider their

WASHINGTON, April 25 — Sen. Bernie Sanders (I-Vt.) today released the following statement in response to Israeli Prime Minister Netanyahu’s claim yesterday that criticism of the Israeli government’s policies is antisemitic: No, Mr. Netanyahu. It is not antisemitic or pro-Hamas to point out that in a little over six months your extremist government has killed 34,000 Palestinians and wounded more

WASHINGTON, April 24 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today sent a letter to the CEO of Novo Nordisk, launching an investigation into the outrageously high prices his pharmaceutical company is charging for Ozempic and Wegovy in the United States. In his letter, Chairman Sanders wrote, “The scientists at Novo Nordisk deserve